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Abstract
The molecular mechanisms regulating the activity of the TCRa gene are required for the production of the circulating T cell
repertoire. Elements of the mouse TCRa locus control region (LCR) play a role in these processes. We previously reported
that TCRa LCR DNA supports a gene expression pattern that mimics proper thymus-stage, TCRa gene-like developmental
regulation. It also produces transcription of linked reporter genes in peripheral T cells. However, TCRa LCR-driven
transgenes display ectopic transcription in B cells in multiple reporter gene systems. The reasons for this important
deviation from the normal TCRa gene regulation pattern are unclear. In its natural locus, two genes flank the TCRa LCR,
TCRa (upstream) and Dad1 (downstream). We investigated the significance of this gene arrangement to TCRa LCR activity
by examining transgenic mice bearing a construct where the LCR was flanked by two separate reporter genes. Surprisingly,
the presence of a second, distinct, reporter gene downstream of the LCR virtually eliminated the ectopic B cell expression of
the upstream reporter observed in earlier studies. Downstream reporter gene activity was unaffected by the presence of a
second gene upstream of the LCR. Our findings indicate that a gene arrangement in which the TCRa LCR is flanked by two
distinct transcription units helps to restrict its activity, selectively, on its 59-flanking gene, the natural TCRa gene position
with respect to the LCR. Consistent with these findings, a TCRa/Dad1 locus bacterial artificial chromosome dual-reporter
construct did not display the ectopic upstream (TCRa) reporter expression in B cells previously reported for single TCRa
transgenes.
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Introduction
The molecular mechanisms resulting in T cell-lineage specific
gene expression are the subject of much investigation. These
studies focus on defining the cis-acting DNA sequences governing
the expression of T cell-specifically expressed gene loci, as well as
the targets, regulation and activity of a small number of T-lineage
biased transcription factors. The picture emerging from these
efforts is not a simple one, as the set of transcription factors
induced during the stages of T cell commitment are generally not
T lineage-specific [1]. Furthermore, in vivo, transgenic studies of
gene regulatory DNA from archetypal T lineage-specifically
expressed gene loci, such as those encoding T cell receptor
(TCR)-a and TCR-b chain proteins, report ectopic activity of
these cis-acting elements in B cells [2–4]. Thus, it is apparent that
achieving a more complete understanding of the T-cell gene
expression program will require consideration of a wider range of
regulatory interactions at gene loci whose products help define the
T lineage.
The mouse TCRa gene exists in a complex multi-gene locus on
mouse chromosome 14. It is subjected to multiple levels of
regulation to produce a specific order and pattern of gene
rearrangements and transcription [5–7]. This locus contains three
differentially expressed genes [TCRa, TCRd and defender against
death (Dad)-1] [8]. This gene arrangement is evolutionarily
conserved [9] and juxtaposes the tightly regulated, T cell specific
TCR genes with the widely expressed Dad1 gene. The latter
encodes a protein with anti-apoptosis function [10] that is required
for early embryonic development [11–13]. The conservation of
this curious juxtaposition raises questions of its potential functional
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TCRa and Dad1 are highly active, and in B cells, where Dad1 is
active, but TCRa is not. In between these two genes lies a stretch
of non-coding DNA that supports locus control region (LCR)
function [14]. An LCR is distinguished from other cis-acting gene
regulatory elements by its ability to function with predictable
activity levels and patterns independently of its site of integration
in the genome of transgenic mice [15]. The TCRa LCR has been
amply demonstrated to confer high-level, lymphoid organ-specific,
copy number-related, integration site-independent expression
upon linked transgenes in mice [4,14,16,17]. Because TCRa
LCR DNA contains elements supporting both T cell specific [17]
and widely-active [16,18,19] gene regulatory function, we initially
hypothesized that it may play a role in regulating and/or
coordinating the distinct expression patterns of both the TCRa
and Dad1 genes flanking it.
We previously reported that TCRa LCR activity faithfully
mimics that of the endogenous TCRa gene during the thymus
stages of T cell development including activation at the
CD4
negCD8
negCD25
negCD44
neg (DN4) thymocyte stage [4].
However, LCR DNA alone was unable to support certain aspects
of TCRa gene regulation in the periphery. As alluded to above,
significant and reproducible ectopic LCR activity was seen in B
cells. These data were generated using single-reporter genes
linked, in the natural TCRa gene position, 59 of the LCR DNA
[4]. Therefore, in this system, the LCR lacks several prominent
features of its endogenous milieu, including the presence of a gene
downstream of it, as well as the specific DNA sequences of the
wider TCRa and Dad1 gene loci. We hypothesized that some, or
all, of these features provided crucial cis-regulatory information
necessary for proper peripheral regulation of TCRa gene
expression and proper modulation of TCRa LCR function.
To broaden our perspective on the possible roles of the TCRa
LCR in the regulation of the genes that flank it, we created LCR-
driven transgenic constructs that contain two separate reporter
genes flanking the LCR. One is heterologous and features the
human CD2 reporter gene previously studied [20] in the TCRa
position with respect to the LCR, and an HLA-B7 reporter
fragment linked 39 to the LCR in the normal Dad1 position [21].
The second is a TCRa/Dad1 bacterial artificial chromosome
(BAC) construction in which separate Va and Dad1 promoter
driven reporter genes flank the LCR DNA in its natural context of
DNA sequence spanning from the Ca exons through the entire
Dad1 genomic locus. Among the significant findings we report
here is that neither of the 59-flanking genes in these ‘‘two-gene’’
reporter systems displayed the ectopic B cell expression that was
observed from ‘‘single-gene’’ Va promoter-driven [2,3] and
heterologous promoter driven [4] reporter constructs studied
previously. These data are consistent with a model in which
flanking the TCRa LCR with two distinct, active genes results in a
T cell restriction to its activity on the upstream-linked gene. This
unexpected inter-gene cis-regulatory interaction may be an
important component of the mechanisms generating T-lineage
specificity of TCRa gene activity.
Results
TCRa LCR-driven single-reporter and dual-reporter
transgenes
In its native locus, two genes flank the TCRa LCR in the
genome (Fig. 1A). To mimic this gene arrangement, we created
reporter transgene constructs where the LCR was linked to a
single reporter gene on either its 59-o r3 9-end. We also created a
‘‘dual-reporter’’ transgene in which the LCR is flanked by the two
different reporter genes at once (Fig. 1B). A human CD2 genomic
fragment occupies the normal position of the TCRa gene, linked
to the 59 end of DNase I hypersensitive sites (HS) 1-8 of the LCR.
Linked to the 39-end of the LCR, in the Dad1 position, is an HLA-
B7 genomic fragment. The two single-reporter transgenes
examined here were named hCD2:1-8 and 1-8:B7. The dual-
reporter transgene was named hCD2:1-8:B7. We previously
reported the activity of the hCD2-1:8 transgene [4] which encodes
a truncated hCD2 protein missing the signaling portion of its
cytoplasmic tail [20]. The HLA-B7 reporter has been used
previously by others as a transgenic reporter gene [21,22]. It was
chosen as our 39 reporter gene for this system because it encodes a
Class I antigen presentation molecule that, like the Dad1 gene, can
be expressed by most cell types. Both gene fragments used are
devoid of LCR activity and, thus, are very poorly expressed on
their own [21,23]. Therefore they are suitable reporters of TCRa
LCR activity. With these constructs, we initially aimed to test if the
TCRa LCR was capable of conferring its powerful regulatory
function upon two unrelated genes flanking it simultaneously.
Because the TCRa LCR’s natural gene neighbors have radically
different expression patterns, we also sought to determine the
significance of gene position (with respect to the LCR) to the
expression pattern of the reporter genes. Nine independent lines of
transgenic mice, three for each construct, were created by
pronuclear microinjection to enable an in vivo examination of
these questions.
The TCRa LCR supports high-level, integration-site
independent expression of two simultaneously flanking
genes
We examined the mRNA levels produced in thymocytes from
the transgene constructs described in Figure 1. PhosporImager
analyses of northern blot assays indicated that both the hCD2 and
HLA-B7 reporter genes were highly expressed (Fig. 2). Further-
more, reporter mRNA levels were also transgene copy number-
related. In both single- and dual-reporter transgene contexts,
Figure 1. The genomic locus of the TCRa LCR and transgene
constructs. (A) Scale diagram of the TCRa/Dad1 genomic locus
containing the TCRa LCR. (B) Diagrams (not drawn to scale) of the three
heterologous TCRa LCR reporter transgenes used in these studies. Note
that the hCD2 transgene is in the position of the TCRa gene with
respect to the LCR sequences. In contrast, the HLA-B7 reporter gene is
in the position of the Dad1 gene. Vertical arrows and numbers indicate
the nine identified DNase I hypersensitive sites (HS) of the LCR.
Horizontal arrows indicate the transcription orientation of the genes
depicted. Solid boxes indicate exons. The asterisk denotes the
placement of a premature stop codon.
doi:10.1371/journal.pone.0015527.g001
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only within the narrow two- to three-fold range consistent with the
integration-site independence of LCR activity [24]. These results
demonstrate that the TCRa LCR can confer a major hallmark of
LCR-driven gene expression, integration-site independence, upon
two unrelated flanking genes at once.
As expected, the relative tissue distribution of the upstream
hCD2 reporter mRNA showed the highest levels in lymphoid
Figure 2. Integration site-independent expression of two reporter transgenes concurrently flanking the TCRa LCR. (A&C) Northern
blot analyses of thymocyte mRNA from hCD2 and HLA-B7 reporter trasngenes linked concurrently (or individually) to opposite sides of the TCRa LCR.
Transgenic line numbers are indicated. NTG = non-transgenic. (B&D) PhosporImager analyses of northern blot experiments. The graphs depict the
mean (+/2 S.E.) of three representative experiments. Y-axis values indicate the percent of the maximum transgenic hCD2 mRNA signal per copy
(normalized to endogenous TCRa mRNA signal) observed in each experiment. The copy number-related (within a narrow 2–3 fold range)
characteristic of full LCR activity is orientation-independent and conferred upon both reporter genes in single-reporter and dual-reporter transgene
contexts.
doi:10.1371/journal.pone.0015527.g002
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organs (Fig. 3A, 3B). Curiously, HLA-B7 transcript levels were
also highest in the thymus and spleen of transgenic mice (Fig. 3B,
3C). In non-lymphoid organs, HLA-B7 reporter expression was
higher (4–14%, of thymus levels) than those observed for the
hCD2 reporter (0–2%). This finding would be consistent with the
much wider tissue-distribution of the Dad1 gene normally found
on the LCR’s 39-flank in the genome. Nevertheless, high-level
expression of the endogenous Dad1 gene does not show the strong
bias towards lymphoid organs displayed by the HLA-B7 reporter
gene. Previous studies have shown that relative Dad1 mRNA
levels seen in thymus and spleen is comparable to those seen in
other organs [8]. Therefore, while the TCRa LCR is able to
support high-level transcription of a 39-flanking reporter gene that
is protected from integration site-dependent position effects, it
alone cannot confer upon the reporter the wide tissue-distribution
of high-level activity characteristic of Dad1 gene expression.
Placement of a second gene 39 of the LCR suppresses
ectopic expression of a 59-LCR-flanking reporter gene in
B cells
The hCD2 reporter transgene is amenable to flow cytometry
analyses. We therefore examined hCD2 expression levels in
splenic T and B cell populations using fluorochrome-conjugated
antibodies specifically recognizing the human CD2 protein (Fig. 4).
As previously reported, significant levels of transgene expression
(15–40% of thymus levels) are seen in spleen B cells in multiple
independent lines of ‘‘single-reporter’’ hCD2:1-8 transgenic mice
[4]. Surprisingly, levels of hCD2 protein detected in B cells from
the ‘‘dual-reporter’’ hCD2:1-8:HLAB7 transgene were much
lower (2–5% of thymus levels) than those observed from the
single-reporter transgene. The hCD2 gene fragment used in both
transgene constructs is identical. Furthermore, as shown in
Figure 2, thymus expression levels per copy of hCD2 from both
the single- and dual-reporter transgenes are comparable. There-
fore we detect a selective suppression of ectopic hCD2 reporter
gene expression in B cells when the HLA-B7 gene is placed
downstream of the LCR.
The protein product of the HLA-B7 gene fragment utilized here
was undetectable by flow cytometry, likely due to the absence of
human b2 microglobulin in our system. Therefore, to examine
expression of this reporter gene in B cells, we employed magnetic
bead (MACS) technology to purify the B cell populations from
transgenic mouse spleen, and prepared RNA from the isolated
cells. Northern blot analyses (Fig. 5) showed that, similar to the
hCD2 single-reporter transgene, significant HLA-B7 gene expres-
sion is observed in B cells of HLA-B7 single-reporter (1-8:B7)
transgenic mice. Normalized reporter mRNA levels ranged from
21% to 32% of thymus levels as detected by PhosphorImager
analyses. In contrast to the suppression of hCD2 reporter gene
expression in B cells observed in the presence of a second reporter
gene flanking the LCR, HLA-B7 mRNA levels in B cells were
unchanged by the presence of the additional hCD2 reporter gene
upstream of the LCR (Fig. 6). HLA-B7 transcript levels in the
dual-reporter transgene ranged from 17 to 33% of thymus mRNA
levels. Similar to the flow cytometry data shown in Figure 4,
reporter hCD2 mRNA levels produced by the dual-reporter
transgene in B cells were very low (1–6% of thymus levels).
Since HLA-B7 reporter expression in B cells is not affected by
the placement of a second reporter gene into the transgene
construct, these data indicate that the suppression of hCD2
reporter gene expression in B cells is not merely an artifact created
by the presence of the dual reporters in the transgene. Rather, the
addition of a second gene downstream of the LCR reveals a
directional negative regulatory activity that limits the expression of
the gene 59 of the LCR to T cells. This is the native position of the
TCRa gene locus relative to the TCRa LCR in the genome.
To corroborate, and gain further mechanistic insight into, the
finding that hCD2 reporter gene expression is more T cell specific
in the dual-reporter transgene context than it is in the single-
reporter transgene construct, we examined the chromatin state of
the hCD2 promoter region in both transgenes. We assayed for the
presence of tri-methyl marks on lysine 4 of Histone H3
(H3K4me3) using chromatin immunoprecipitation (ChIP).
H3K4me3 is an epigenetic histone modification associated with
promoter activation and transcript initiation [25]. Figure 7 shows
the percent H3K4me3 detected at the transgenic hCD2 promoter,
expressed relative to that observed at the endogenous GAPDH
promoter, which is used here as an internal, normalizing standard.
In single-reporter transgenic mice, the fold-enrichment of
H3K4me3 marks at the hCD2 promoter is only ,1.7 to 2.4-
times higher in thymocytes than that seen in spleen B cells. In
sharp contrast, dual-reporter transgenic mice display greater than
8-fold higher H3K4me3 enrichment in thymocytes than the levels
of enrichment observed in B cells. Thus, the levels of epigenetic
chromatin activation detected at the hCD2 promoter in this
system correlate with the cell type-specificity of hCD2 transcript
accumulation observed. These data indicate that the hCD2
promoter region in B cells exists in different local chromatin
conformations in single-and dual-reporter transgene contexts.
A reporter gene 59 of the TCRa LCR is not ectopically
expressed in B cells in the context of a TCRa/Dad1 BAC
transgene
Transgenes under the control of TCRa gene regulatory
elements have previously been reported to be ectopically expressed
in B cells [2,3]. Based on the results of our dual-reporter transgene
described above, we hypothesized that the Dad1 gene normally
present 39 of the TCRa LCR in the genome might serve to
suppress such ectopic B cell expression. Therefore, we examined
the expression of a TCRa V-region promoter driven hCD2
reporter cDNA placed 59 of the TCRa LCR in the context of a
bacterial artificial chromosome (BAC) containing 78-kb of DNA of
the mouse TCRa/Dad1 locus. The BAC begins upstream of the
Ca exons and spans the entire Dad1 gene locus including a 5.4-kb
segment of non-coding DNA upstream of Dad1 Exon 1 that would
contain its putative promoter region. A cDNA encoding a
cytoplasmic tail-less version of hCD2 was fused in frame to the
ATG translation start codon contained in a Va11.1 promoter
fragment [14,26]. This reporter cassette was then recombined into
the BAC in a position 180-bp upstream of Ca exon 1. As a
reporter of Dad1 promoter function, a cDNA coding for rat CD2
(rCD2), also missing its cytoplasmic tail [27], was recombined into
the BAC in frame with the Dad1 ATG start codon, thus replacing
most of Dad1 exon 1. Figure 8 shows northern blot data
demonstrating that rCD2 mRNA expression from the BAC is
widespread and readily detectable in multiple organs. This
indicates that the reporter BAC harbors an active Dad1 promoter.
No hCD2 protein was detectable on BAC transgenic lympho-
cyte cell surfaces by flow cytometry due to aberrant splicing we
encountered of the hCD2 reporter (at base pair # 618 in the open
reading frame of the hCD2 cDNA) to Ca exon 1 (data not shown).
To circumvent this problem, we designed a real time, RT-PCR
strategy to detect this BAC-specific hCD2-Ca fusion transcript.
Using this quantitative assay, we examined Va-promoter driven
reporter gene activity from the BAC in thymocytes and isolated
spleen B cells of BAC transgenic mice (Fig. 9A). In these
experiments, B cell hCD2 reporter mRNA expression detected
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PLoS ONE | www.plosone.org 4 November 2010 | Volume 5 | Issue 11 | e15527Figure 3. Lymphoid organs express the highest levels of both hCD2 and HLA-B7 reporter transgenes. PhosphorImager analyses of
northern blots of RNA prepared from the indicated tissues of the hCD2:1-8 (A), hCD2:1-8:B7 (B) or 1:8-B7 (C) transgenic mice. Reporter mRNA levels
are quantified and normalized to 18S rRNA signal. Y-axis values represent the mean (+/2 S.D.) expression levels relative to the thymus (designated as
100%) observed among three independent lines of mice bearing the indicated transgene.
doi:10.1371/journal.pone.0015527.g003
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from simultaneous analyses of endogenous TCRa mRNA. Thus,
unlike the Va promoter-driven (single transcription unit) trans-
genes studied previously [2,3], the Va promoter-driven hCD2
reporter gene in the dual-reporter TCRa/Dad1 BAC does not
display ectopic expression in B cells. Figure 9B shows RT-PCR
data confirming that, as expected, the Dad1 promoter driven
rCD2 reporter gene is active in B cells of the BAC transgenic mice.
Discussion
In this report we describe two important new findings regarding
the properties of the TCRa LCR and make a significant advance
in our understanding of its capacity to generate T cell restricted
gene expression. First, we have determined that the sequences of
the LCR alone are insufficient for conferring a widespread, Dad1
like gene expression pattern upon a reporter gene linked to its 39-
end. Widely-active chromatin activating elements were previously
discovered in the 39-DNA of the LCR [16,18,19]. Thus, it was
plausible that these elements could provide a more ubiquitous
expression pattern to a 39-linked gene than it would to a 59-linked
gene, upon which a lymphoid organ specific pattern is conferred
by the full LCR [4,16]. Although these data do not rule out a role
for the LCR in Dad1 gene expression, other elements in the Dad1
locus are clearly required to generate the full widespread
expression pattern characteristic of this gene.
Several LCRs, including those from the human b-like globin
[28], VpreB/l5 [29], Th2 cytokine [30] and human growth
hormone [31] gene loci have been shown to regulate their
multiple, related, naturally occurring target genes. We find that in
T cell-bearing organs in vivo, the TCRa LCR is capable of
conferring high-level integration-site independent, copy-number
related gene expression upon two heterologous and unrelated genes
that flank it simultaneously. It is likely that the LCR achieves this
dual-gene activation function via dynamic and alternating
interactions with the upstream and downstream genes. Alternating
gene-LCR interactions have been observed in the b-globin multi-
gene locus [28]. That we demonstrate the LCR’s ability to regulate
two unrelated flanking genes is significant because this is the LCR’s
natural state in the endogenous locus. It further supports the
notion that elements of the LCR may be involved in regulating its
natural 39 neighbor, the Dad1 gene, despite the fact that its
expression pattern is radically different from that displayed by
TCRa. That the two flanking, unrelated genes can be heterologous
Figure 4. Ectopic TCRa LCR-driven upstream reporter gene (hCD2) expression is strongly suppressed by adding a second gene
(HLAB7) downstream of the LCR. (A) Flow cytometry analyses of spleen lymphocytes from (at left) single-reporter hCD2-LCR (10 transgene
copies) and (at right) two-reporter hCD2-LCR-B7 (3 transgene copies) transgenic mice. hCD2 levels are shown for spleen T cells (gated on Thy1+ cells)
and spleen B cells (gated on CD19+ cells). Dashed curves indicate the non-transgenic spleen control signal. (B) Graph depicting mean fluorescence
intensity (MFI) of hCD2 reporter protein staining in paired samples of thymocytes and isolated B cells (from the same mouse). Shown are three
independent lines each of single-reporter hCD2-LCR and two reporter hCD2:1-8:B7 transgenic mice. MFI is normalized to thymocyte hCD2 expression
(100%). In all cases, the substantial ectopic B cell expression of hCD2 seen from the single-reporter transgene is virtually eliminated in the presence of
a second reporter gene downstream of the LCR.
doi:10.1371/journal.pone.0015527.g004
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a high degree of potential utility of the TCRa LCR in the design
of vectors for genetic engineering of T cells. Several envisioned
gene therapy applications require expression of multiple proteins
in T cells. The most obvious of these would be the introduction of
pre-rearranged TCRa and TCRb chains that, together, would
encode a receptor targeting diseased cells [32–34].
The question of the mechanisms generating cell type-specific
patterns of lymphocyte antigen receptor gene rearrangement and
expression has been the focus of much study. In general, TCR
genes are activated, assembled and transcribed in T cells but not B
cells. The activity of the endogenous TCRa gene is T cell
restricted. A recent comprehensive study of transcription factor
expression during T lineage commitment has confirmed a small
group of such factors (GATA-3, TCF-1 and Bcl11b) as T lineage-
specific with respect to lymphocyte development [1]. The activity
of members of this group of factors may contribute to the
specificity of TCRa gene expression. TCF-1 has been clearly
implicated in TCRa gene expression [35]. However, TCF-1
activity has also been found to be redundant to that of LEF-1
[35,36] which is also expressed in B cells. GATA-3 has long been
suspected of involvement in TCRa enhancer (Ea) function [37].
However, subsequent studies have found GATA-3 activity to be
dispensable for the function of both TCRa and TCRb enhancers
[38]. Furthermore, GATA-3 becomes differentially expressed
among the classes of ab TCR-bearing cell subsets and thus plays a
role in the specialization of CD4 versus CD8 [39] and T helper-2
versus T helper- 1 cell [40] subsets. In addition, Runx and Ets
family proteins have been shown to interact in vivo with functional
DNA in the Ea/HS1 [41] and HS6 [18,19] regions of the TCRa
LCR. However, these proteins are generally not T cell restricted
[1] and, in fact, are important for gene regulation in B cells [42].
Therefore, despite these important advances, a clear explanation
for the restriction of TCRa gene expression to T cells has
remained elusive. Nevertheless, this existing information may
explain why TCRa transgenes removed from their natural
genomic context [3] as well as other transcription units under
the control of TCRa gene regulatory elements, such as the TCRa
LCR, become expressed in both T and B cells. The latter is true
whether or not transcription from the transgene construct is driven
by a natural Va promoter [2] or a heterologous promoter [4]. It is
important to determine the reasons for this discordance between
the endogenous TCRa locus and TCRa transgenes. The
integration site-dependent position effects that transgenes can be
subject to cannot explain this discrepancy. This is because ectopic
B cell expression is seen from transgenes under the control of the
complete TCRa LCR that, generally, are not susceptible to such
position effects. Furthermore, aberrant expression of TCR chain
genes in B cells appears to have deleterious consequences for B
cells homeostasis in vivo [3]. Therefore, the further development of
more physiological TCR transgenic mouse models, as well as
potential TCR gene therapy applications, will require an
understanding of how to restrict to T cells the TCRa mRNA
generated from integrated transgene constructs.
Figure 5. The TCRa LCR drives significant mRNA expression levels of a 39-linked HLA-B7 reporter gene in B cells. (A) Northern blot
analyses of RNA prepared from thymocytes and isolated spleen B cells from three independent lines of 1:8-B7 transgenic mice. Thy = Thymus, SpB =
Spleen B cells, NTG = non-transgenic. (B) Graph depicting PhosporImager analyses of HLA-B7 reporter expression levels normalized to 18S rRNA. Y-
axis values are expressed relative to thymus mRNA levels (designated as 100%).
doi:10.1371/journal.pone.0015527.g005
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clue towards this goal. We found that the activity of the TCRa
LCR, which in the genome is normally flanked by two distinct
genes, is qualitatively altered by such a two-gene arrangement.
The placement of a second, distinct reporter transcription unit
downstream of a TCRa LCR fragment already linked to an
upstream reporter gene suppresses ectopic expression of that
upstream reporter gene in B cells. This unexpected inter-gene cis-
regulatory interaction is observed in dual-reporter transgenic
constructs employing heterologous (hCD2/HLA-B7) promoters.
Prior to these findings, the most obvious explanation for the lack of
strict T cell-specificity of transgenes under the control of TCRa
LCR would have been the lack of specific, unidentified cis-
elements of the wider endogenous TCRa/Dad1 gene locus in the
transgene construction. However, our data would seem to argue
against this simple hypothesis. The heterologous reporter gene
system utilized here shares the ‘‘two-flanking-gene’’ arrangement
about the TCRa LCR that is a feature of the TCRa/Dad1 gene
locus. However, it is unlikely to share specific sequence elements
(outside of the LCR) with the endogenous locus.
How might the findings described above apply to TCRa gene
regulation? It has been shown that TCRa LCR-driven single
reporter transgenes under the control of Va [2] (as well as hCD2
and b-globin promoters [4]) become expressed in B cells. TCRa
single-transgene constructs under the control of natural Va
promoters have also been shown to be ectopically expressed in B
cells [3]. These prior data make clear that neither the Va
promoter, nor the full TCRa LCR can fully prevent substantial
ectopic transgene expression in B cells. It is therefore of
significance that we find that the Va promoter-driven reporter
gene upstream of the TCRa LCR (i.e. in the TCRa position) in
our TCRa/Dad1 dual-reporter BAC transgene does not display
such aberrant expression in B cells. All together, these data are
consistent with the notion that the inter-gene cis-regulatory
interaction observed in our heterologous dual-reporter transgene
system may apply to the natural TCRa and Dad1 promoters.
According to the model arising from the heterologous system, the
presence of the Dad1 gene downstream of the LCR in the BAC
would be playing a similar, restricting role to that observed for the
HLA-B7 gene in the heterologous transgene construction. We
cannot yet explicitly rule out that the HLA-B7 and Dad1 genes
serendipitously share a common gene regulatory element that
would be responsible for suppressing TCRa LCR activity in B
cells. But this possibility seems unlikely. However, both genes do
share an active promoter in our experimental systems.
In light of these results, we now hypothesize that having two
distinct viable promoters flanking the TCRa LCR induces a novel
promoter selection mechanism that only permits both promoters
to be simultaneously active in T cells. While we cannot yet propose
a particular molecular mechanism for this inter-gene cis-regulatory
interaction, we can speculate from our data that such a mechanism
will likely require, at a minimum, the presence of two different
promoters and one or more sub-elements of the TCRa LCR that
lies in between them. An example of a cis-acting regulatory activity
that coordinates the function of multiple promoters in complex
gene loci is that supported by the promoter targeting sequence
Figure 6. HLA-B7 reporter mRNA expression in B cells is not suppressed by the presence of a second reporter gene upstream of the
TCRa LCR. PhosphorImager analyses of representative northern blot (bottom right inset) analyzing levels of spleen B cell expression of hCD2 and
HLA-B7 mRNA relative to those observed in thymus (designated as 100% for all lines) in three independent lines (10, 17, 22) of hCD2:1-8:B7 transgenic
mice. Reporter signals are normalized to 18S loading control signal. HLA-B7 expression levels in B cells (B), relative to thymus (T), from this dual-
reporter transgene construct is similar to that seen in single-reporter 1-8:B7 transgenic mice (see Fig. 5). Levels of hCD2 mRNA from the dual-reporter
hCD2:1-8:B7 transgene are as low, relative to thymus, as the hCD2 protein signals detected in flow cytometry (see Fig. 4).
doi:10.1371/journal.pone.0015527.g006
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of the Drosophila Bithorax multi-gene complex. It has been
described to have an anti-insulator function. Insulators are cis-
elements that can support enhancer-blocking and/or chromatin
barrier function [44]. In general, they serve to prevent functional
in cis interactions of gene regulatory elements positioned on
opposite sides of it. The anti-insulator function of the PTS would
thus selectively enable an enhancer to activate a distant promoter
even if an insulator exists between them.
The presence of multiple promoters and an insulator in a
transcription unit enables the PTS to display a promoter targeting
activity. In experiments with transgenic Drosophila embryos, this
function of the PTS restricts an enhancer to a functional
interaction with only one promoter when two are present in the
same transgene [45]. With respect to the TCRa/Dad1 gene locus,
the connection of PTS activity to insulators is intriguing. Multiple
insulator activities have been described within the TCRa LCR of
both enhancer blocking [46,47] and putative chromatin barrier
[19,48] types. The DNA region containing these insulator-like
activities has an apparent impact on the regulation of the TCRa
locus [8,49] and sub-elements within this DNA region are required
for TCRa LCR activity in vivo [19,48]. Thus, it is plausible that
insulator and PTS-like activities may be cooperating to produce
the differential expression patterns of reporter genes representing
TCRa and Dad1 in T versus B cells when two distinct
transcription units are present.
An alternative hypothesis would invoke a competition between
the two distinct promoters for the regulatory activity of the TCRa
LCR. The simplest explanation for any such competition would be
based on relative promoter strength or position as has been
hypothesized in prior studies [50]. In our transgene systems, the
downstream (HLA-B7 and Dad1) promoters are normally more
widely active than the upstream (hCD2 and Va) promoters. Thus,
it is also conceivable that a competition model can be based on the
more ubiquitous nature of the downstream promoters used in the
present study. In any case, exploring these hypotheses would be
the next steps to take in understanding the coordination of the
disparately regulated genes in the complex and immunologically
important TCRa/Dad1 gene locus.
Materials and Methods
This research was reviewed and approved by the Hunter
College Institutional Biosafety Committee and the Hunter College
Institutional Animal Care and Use Committee (protocol # BO-
10/11-02)
DNA constructs and transgenic mice
Transgenic mice were generated by pronuclear microinjection
as described previously [48]. The hCD2:1-8 transgene was also
previously described [4]. Briefly, a cytoplasmic tail-less hCD2
(hCD2DT) reporter gene [20] was linked to a 9.5-kb TCRa LCR
cassette containing the DNase hypersensitive sites (HS)-1-8 [16].
Three independent mouse lines containing this construct were
utilized in this study. The relative transgene copy number in the
three lines (4, 29, 44) was determined to be 10, 5, and 5,
respectively. The 5.5 kb EcoRV-BamHI human HLA-B7 geno-
mic fragment (from J. Chamberlain via gift of G. Siu) previously
described is devoid of the activity of its natural, cognate LCR [21].
This fragment was linked to the 39 portion of the above-described
TCRa LCR cassette in a transcriptional orientation similar to that
of the Dad1 gene with respect to the LCR. Microinjection of this
construct, called 1-8:B7, yielded 3 independent transgenic lines
(13, 40, and 50) with copy numbers of 5, 5, and 10, respectively.
The ‘‘dual-reporter’’ hCD2:1-8:B7 transgene is a construct that
has the two above described reporter genes, hCD2DT and HLA-
B7 simultaneously flanking the TCRa LCR. Here, hCD2DT was
inserted 59 of the TCRa LCR cassette and the HLA-B7 reporter is
39 of the LCR. Three independent transgenic mouse lines bearing
this construct were established (lines 10, 17, 22) with copy numbers
of 3, 3, and 7, respectively.
Bacterial artificial chromosome modification and
constructs
The TCRa/Dad1 Bacterial Artificial Chromosome (BAC)
reporter construct was based on BAC clone RP23-94I14 (I14)
(BACPAC Resources, Oakland, CA). This BAC encompasses the
TCRa/Dad1 locus ranging from about 90 kb upstream of the
TCRa constant region to approximately 59 kb downstream of the
Figure 7. Increased T cell-selectivity of epigenetic hCD2
promoter chromatin activation in the dual-reporter transgene
context. (A) Chromatin immunoprecipitation assay on thymocytes and
isolated spleen B cells detecting the trimethyl-lysine 4 epigenetic mark
on Histone H3 from single reporter (hCD2:1-8 line 4) and dual-reporter
(hCD2:1-8:B7 line 10) transgenic mice. Y-axis values represent the ratio
of percent H3K4me3 marks obtained at the hCD2 promoter to that
detected at the endogenous GAPDH promoter, an internal standard
used here as a normalizing control. (B) Confirmation of ChIP results
using distinct, independent lines of transgenic mice bearing single
reporter (hCD2:1-8 line 29) and dual reporter (hCD2:1-8:B7 line 22)
transgenes. For both experiments, the Y-axis values are derived from
the formula hCD2 [H3K4me3 – IgG/input]/GAPDH [H3K4me3 – IgG/
input].
doi:10.1371/journal.pone.0015527.g007
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ET Recombination system (Genebridges, Dresden, Germany). As
a reporter for the TCRa gene, a separate transcription unit
(named Va11.1hCD2DT) containing the Va11.1 promoter from
the pVCaK transgene [14] was inserted in frame with a cDNA
encoding a cytoplasmic tail-less hCD2 protein (hCD2DT – a gift of
M. Bevan). The 1680 bp Va11.1hCD2DT fragment was inserted
180-bp upstream of the TCRa constant region in the same
transcriptional orientation as TCRa. Similarly, a 703 bp rat CD2
reporter cDNA (also lacking the cytoplasmic tail) [27], was
recombined into the BAC clone in frame with the ATG residing in
the first exon of the Dad1 transcription unit. This also removed
most of Dad1 exon 1 from the BAC. The resulting BAC construct
was further modified by deleting 90-kb immediately upstream of
the introduced Va11.1hCD2DT fragment. This final construct
named D59I14h/rCD2 was digested with Not I to liberate the
insert from the BAC vector. Because of a naturally occurring Not I
site in the BAC insert, this digestion also removes about 17-kb
between the 39 end of the BAC vector and the Dad1 gene. The
resulting fragment of 77.9-kb was purified and used to generate
transgenic mouse lines. Two independent transgenic mouse lines
bearing this fragment intact were generated and analyzed.
RNA analyses
RNA from mouse organs was prepared as previously described
using a single step isolation protocol [51]. Mouse tissues were
dissected of fat and washed with phosphate buffered saline to
minimize blood contamination then placed in RPMI containing
5% FBS until homogenized. Alternatively, purified T cells and B
cells were isolated using a magnetically activated cell separation
system (MACS, Miltenyi Biotec Auburn, CA) prior to RNA
extraction. All MACS isolated populations were greater than
90% pure by flow cytometry analyses. Northern blot experiments
were carried out using 5 mg RNA/sample run on 1% agarose
gels. Samples were transferred to non-charged nylon membrane
(Genescreen, Perkin Elmer, Waltham, MA) for hybridization
using Quickhyb solution (Stratag e n e ,L aJ o l l a ,C A ) .H u m a nC D 2
transgene mRNA was detected using a 0.5 kb Eco RV-Pst Ip r o b e
from exon II of the human CD2 gene while HLA-B7 mRNA was
detected with a 2 kb Bgl II genomic fragment. The 703-bp rCD2
cDNA was used to probe for transgenic rCD2 mRNA. To
normalize for loading variation, blots were stripped and re-
probed with a 0.5 kb Sau 3AI fragment of a TCRa constant
region(Ca) cDNA or 18SrRNA probe (Ambion,Austin, TX). All
probes were labeled with [a-32P]dCTP using a random primer
labeling kit (Invitrogen, Carlsbad, CA). Transgene signals were
normalized and quantified by PhosphorImager analyses (GE,
Pittsburg, PA).
Real-Time, reverse transcriptase-PCR analyses
Thymocytes and spleen B cells, isolated using the MACS
separation technology (Miltenyi Biotech, Auburn, CA) from BAC
transgenic mouse lines were analyzed by real-time, reverse
transcriptase PCR. RNA was prepared from isolated cells as
described above. First strand synthesis from the RNA samples was
performed with the Protoscript kit (NEB). Approximately100 ng of
Figure 8. A TCRa/Dad1 reporter BAC transgene harbors an active Dad1 promoter. (A) Diagram of the TCRa/Dad1 dual-reporter BAC
construct. VahCD2 refers to the TCRa V-region promoter driving a human cytoplasmic tail-less human CD2 cDNA. The rCD2 refers to the BAC-resident
Dad1 promoter driven rCD2 reporter cDNA. The TCRa constant region exons (Ca), HS of the TCRa LCR (small arrows) and Dad1 exons are shown. The
Not I sites shown are ,78-kb apart. (B) Representative northern blot analysis of rCD2 reporter expression from BAC transgenic line 86 in the indicated
organs. The 18S signal is used as a loading control. (C) PhosphorImager analyses of northern blot experiments examining rCD2 reporter gene
expression in the indicated organs of individuals representing two independent BAC transgenic mouse lines. The distribution of mRNA levels is
expressed relative to the levels observed in the thymus.
doi:10.1371/journal.pone.0015527.g008
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according to the manual of the kit. Typically, 1/10 of the first
strand synthesis reaction was used to set up PCR reactions using
the components of the HotStart kit (NEB). Real time PCR was
carried out in an Applied Biosystems 7500 real time PCR system.
The primers used to detect the BAC-specific reporter hCD2/Ca
transcript were (forward) 59-AGGGAACAAAGTCAGCAAGGA-
39 and (reverse) 59-GGAGGATTCGGAGTCCCATAAC-39.T o
detect endogenous TCRa mRNA, primers used were (forward) 59-
AAGATCCTCGGTCTCAGGACA-39 and (reverse) 59-AGCA-
ACCTTCCTCACAAATCTG-39. Primers used to detect the
BAC-specific rCD2/Dad1 transcript were (forward) 59-AGCTG-
TACCAAGGAAAGGAGCAT-39 and (reverse) 59- AGTTCAT-
GACGACAAGGTGCAG-39. Primers used to specifically detect
endogenous Dad1 mRNA were (forward) 59-GGCACTGGA-
CTTGAGGATTCTA-39 and (reverse) 59-GGAAAGTAAGG-
GCTACAGTGAGG-39. Primers used to detect b-actin were
(forward) 59-GAGCACAGCTTCTTTGCAGCT-39 and (reverse)
59-AGCCTGGATGGCTACGTACAT-39.
Flow Cytometry
Single cell suspensions of thymocytes and spleen cells were
treated in FACS stain buffer (RPMI 1640, 3% FBS, and 10 mM
HEPES buffer). 10
6 cells in 100 mL were blocked for 20 minutes
4uC with an excess of normal mouse IgG. Cells were stained with
0.2–1.0 mg of antibody for 20 minutes at 4uC. Three washes in
FACS stain buffer were done before flow cytometry analysis. In
addition to analyses of thymocytes, Mouse anti-mouse CD90.2/
Thy1 (Invitrogen) was used to detect splenic T cells. Rat anti-
mouse CD19 (BD Pharmingen, San Jose, CA) identified splenic B
cells. The appropriate population was gated, analyzed, and
compared in both non-transgenic and transgenic cells for hCD2
expression using mouse anti-hCD2 (clone S5.2 - BD Pharmingen).
Acquisition and analyses was done using FACScan (BD) and Cell
Quest Pro software.
Chromatin Immunoprecipitation (ChIP)
Thymocytes and B cells of analyzed transgenic mouse lines were
fixed in 10 ml RPMI medium with 1% formaldehyde at room
Figure 9. Ectopic TCRa/hCD2 reporter gene activity is absent in B cells of TCRa/Dad1 dual-reporter gene BAC transgenic mice. (A)
Real-time reverse transcriptase-mediated PCR experiments on RNA prepared from thymocytes and isolated B cells from individual TCRa/Dad1 dual-
reporter BAC transgenic mice. Y-axis values indicate the relative hCD2-Ca reporter (open bars) and endogenous TCRa (filled bars) mRNA levels within
an individual mouse (thymocyte level designated as 100%). hCD2-Ca reporter mRNA signals ranged from ,10–20% of endogenous TCRa mRNA
levels. The normalizing control mRNA was b-actin. Experiments on two separate individual mice per each of two independent BAC transgenic lines
are shown. (B) The Dad1 promoter on the BAC is active in B cells. Real time RT-PCR detection of BAC-resident, Dad1 promoter-driven rCD2 reporter
expression from B cells isolated from individual BAC transgenic mice. The data are normalized to endogenous Dad1 mRNA levels.
doi:10.1371/journal.pone.0015527.g009
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600 ml of 2 M Glycine and the cells were harvested. The cells were
washed twice with 16PBS and the cell pellets were re-suspended
in 1 ml 16micrococcal nuclease (MNase) buffer (NEB) containing
2.5 ml protease inhibitor cocktail (Sigma) and 1 ml 100 mM PMSF.
Nucleosomes were prepared by incubating with 500 units of
MNase (NEB) for 10 minutes at 37uC. The reaction was stopped
by adding 100 ml 0.5 M EGTA, pH 7.4. The chromatin was then
harvested by micro-centrifugation at top speed at 4uC. The
supernatant was transferred to a new tube. To 100 ml of the
sheared chromatin was successively added: 1 ml protease inhibitor
cocktail, 20 ml ChIP buffer 1, 15 ml of protein G coupled magnetic
beads (all from Active Motif), 25 ml of 10 mg/ml Salmon Sperm
DNA (Invitrogen), 1 ml of 10 mg/ml BSA (NEB), 36 ml deionized
water and 3 ml of 1 mg/ml an antibody recognizing the trimethyl-
lysine 4 modification on histone H3 (anti-H3K4me3) (Abcam). As
a negative isotype control, 3 ml of 1 mg/ml purified normal
Rabbit IgG (Jackson Immunoresearch) was added instead of the
anti-H3K4me3 antibody. ChIP reactions were allowed to proceed
overnight at 4uC. After the immunoprecipitation, the steps for
washing, elution of chromatin, and DNA preparation were
performed as described in the manual of the ChIP-IT Express
kit (Active Motif). 2 ml of each of the resulting DNA solutions were
used as template in standard PCR reactions and the PCR products
were analyzed by Southern blotting. Blots were hybridized with
probes corresponding to each of the expected individual PCR
products. Primers to detect hCD2 promoter region were (forward)
59-GGTGCAGTCTCCAAAGAGATTACG-39 and (reverse) 59-
CTCATCTTAGGGGTTGGTTTCCTC-39. GAPDH promoter
control primers were (forward) 59- GGCTGCGGAAAAGT-
TGTTGAGGA-39 and (reverse) 59- CTGAGTCCTATCCTGG-
GAACCAT-39.
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